Oral undecylinic acid in the prevention of the so-called monilial complications secondary to the use of aureomycin, chloramphenicol and terramycin.
D035843:Biomedical Research; D002175:Candida; D002701:Chloramphenicol / Q000627:therapeutic use*; D002751:Chlortetracycline / Q000008:administration & dosage*; D010118:Oxytetracycline / Q000627:therapeutic use*; D014476:Undecylenic Acids / Q000494:pharmacology*
D014476:Undecylenic Acids; D002701:Chloramphenicol; D002751:Chlortetracycline; D010118:Oxytetracycline
AUREOMYCIN/administration; CHLORAMPHENICOL/therapeutic use; OXYTETRACYCLINE/therapeutic use; UNDECYLENIC ACID/effects